Katrin Hoffman

Chief Scientific Officer

Katrin Hoffmann holds a PhD from the University of Kaiserslautern, Germany and has 20 years combined experience in biomedical and commercial research. She worked 6 years at the Telethon Kids Institute (Perth) in cancer research, establishing a gene profiling program for disease prediction within the paediatric leukaemia unit.

Since joining PYC Therapeutics, Katrin has worked across most facets of the company’s research activities and is an inventor on key patents. At PYC Therapeutics her focus is the identification of novel cell-penetrating peptides (CPPs) and the development of delivery solutions for breakthrough therapeutics in rare diseases.